4.8 Article

A functional alternative splicing mutation in human tryptophan hydroxylase-2

期刊

MOLECULAR PSYCHIATRY
卷 16, 期 12, 页码 1169-1176

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/mp.2010.99

关键词

TPH2; serotonin (5-HT); SNP; alternative splicing

资金

  1. National Institute of Mental Health, NIH
  2. National Institutes of Health [MH079201, MH060451, MH067996, RR017701]
  3. Singapore National Medical Research Council [NMRC/TCR/003-GMS/2008]
  4. Singapore Ministry of Education [T208A3126]
  5. NARSAD
  6. Lennon Family Foundation
  7. CIHR
  8. CPRF
  9. AstraZeneca

向作者/读者索取更多资源

The brain serotonergic system has an essential role in the physiological functions of the central nervous system and dysregulation of serotonin (5-HT) homeostasis has been implicated in many neuropsychiatric disorders. The tryptophan hydroxylase-2 (TPH2) gene is the rate-limiting enzyme in brain 5-HT synthesis, and thus is an ideal candidate gene for understanding the role of dysregulation of brain serotonergic homeostasis. Here, we characterized a common, but functional single-nucleotide polymorphism (SNP rs1386493) in the TPH2 gene, which decreases efficiency of normal RNA splicing, resulting in a truncated TPH2 protein (TPH2-TR) by alternative splicing. TPH2-TR, which lacks TPH2 enzyme activity, dominant-negatively affects full-length TPH2 function, causing reduced 5-HT production. The predicted mRNA for TPH2-TR is present in postmortem brain of rs1386493 carriers. The rs13864923 variant does not appear to be overrepresented in either global or multiplex depression cohorts. However, in combination with other gene variants linked to 5-HT homeostasis, this variant may exhibit important epistatic influences. Molecular Psychiatry (2011) 16, 1169-1176; doi:10.1038/mp.2010.99; published online 21 September 2010

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据